Publisher
Peertechz Publications Private Limited
Reference21 articles.
1. 1. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, et al. (2008) American College of Cardiology/American Heart Association Task Force on Practice; American Association for Thoracic Surgery; Society of Thoracic Surgeons. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary. Heart Rhythm 5: 934-955. Link: https://goo.gl/FegvFp
2. 2. Ottenberg AL, Mueller LA, Mueller PS (2013) Perspectives of patients with cardiovascular implantable electronic devices who received advisory warnings. Heart Lung 42: 59-64. Link: https://goo.gl/oy6a5y
3. 3. Uslan DZ, Crane SJ, Steckelberg JM, Cockerill FR 3rd, St Sauver JL, et al. (2007) Age- and sex-associated trends in bloodstream infection: a population-based study in Olmsted County, Minnesota. Arch Intern Med 167: 834-839. Link: https://goo.gl/ezN29x
4. 4. Smith PN, Vidaillet HJ, Hayes JJ, Wethington PJ, Stahl L, et al. (1998) Infections with nonthoracotomy implantable cardioverter defibrillators: can these be prevented? Endotak Lead Clinical Investigators. Pacing Clin Electrophysiol 21: 42-55. Link: https://goo.gl/G5kxs1
5. 5. Lai KK, Fontecchio SA (1998) Infections associated with implantable cardioverter defibrillators placed transvenously and via thoracotomies: epidemiology, infection control, and management. Clin Infect Dis 27: 265-269. Link: https://goo.gl/H71rhC